Figure 5
![Figure 5. PARP1 inhibition decreases ZFN-mediated translocations in cells of hematopoietic origin. Jurkat cells were treated with olaparib or rucaparib, and translocations induced by ZFN pairs were measured by assaying der[3] formation by using semiquantitative PCR at the indicated times, as shown in Figure 4.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/121/21/10.1182_blood-2012-10-460527/4/4359f5.jpeg?Expires=1735827291&Signature=kMzJBqKV8Q~9J9oyJh~iLYT-hoZZxwTbOA1wRj1LX3b5AHMPFn9YBw~gjAN4TYGmOJDtpQzBqIh7-j4Qvsw3Ari3~EuKre~kcDMpsxjfu5IehloE8FhNSUvg47kvjFfB3fc8~5fF3hg6j~TqEKSzYKpXAfRdOZaxeIZL7fl9eRf~~2XZwe8Zl1MWBO5J09xCJdEPxrLhnHNq9do6TwYcLt4pn4QyC~x9sWD0JjHYt9PGOFOYICCTWa9a0NAx0oC28tCU8mwxCCx03RpLbZR2BCFH5ZJ9qn~TY5iukPi1Ckr0xuhaDoBwNZFzEHyWQpzUWAZINV-T3ahmnU6Y-rDRKg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
PARP1 inhibition decreases ZFN-mediated translocations in cells of hematopoietic origin. Jurkat cells were treated with olaparib or rucaparib, and translocations induced by ZFN pairs were measured by assaying der[3] formation by using semiquantitative PCR at the indicated times, as shown in Figure 4.
